RC3H2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.26487709195544E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.39040000027791E-07 |
Normal-vs-Stage2 |
1.89159999999244E-05 |
Normal-vs-Stage3 |
4.21884749357559E-15 |
Normal-vs-Stage4 |
1.10970121980358E-11 |
Stage1-vs-Stage2 |
2.122600E-01 |
Stage1-vs-Stage3 |
1.55209999996853E-06 |
Stage1-vs-Stage4 |
3.403000E-04 |
Stage2-vs-Stage3 |
5.088500E-02 |
Stage2-vs-Stage4 |
1.084830E-01 |
Stage3-vs-Stage4 |
9.608800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.40363326201532E-12 |
Normal-vs-AfricanAmerican |
4.60219995446209E-09 |
Normal-vs-Asian |
4.255000E-01 |
Caucasian-vs-AfricanAmerican |
1.116010E-01 |
Caucasian-vs-Asian |
3.364400E-01 |
AfricanAmerican-vs-Asian |
1.161160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.65436586441592E-13 |
Normal-vs-Female |
6.46830000672338E-09 |
Male-vs-Female |
1.866190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.834500E-04 |
Normal-vs-Age(41-60Yrs) |
1.94820000132268E-08 |
Normal-vs-Age(61-80Yrs) |
1.53987933515509E-13 |
Normal-vs-Age(81-100Yrs) |
1.03139999996227E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.852200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.413200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.056400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.661700E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.037600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.184400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.205200E-01 |
Normal-vs-Grade 2 |
3.32279999959439E-07 |
Normal-vs-Grade 3 |
1.65756297576536E-12 |
Normal-vs-Grade 4 |
8.72857341960298E-13 |
Grade 1-vs-Grade 2 |
9.833600E-02 |
Grade 1-vs-Grade 3 |
3.143300E-03 |
Grade 1-vs-Grade 4 |
8.231600E-04 |
Grade 2-vs-Grade 3 |
1.457230E-03 |
Grade 2-vs-Grade 4 |
2.201800E-04 |
Grade 3-vs-Grade 4 |
1.167180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.575500E-04 |
Normal-vs-ccB subtype |
1.89126492244895E-12 |
ccA subtype-vs-ccB subtype |
1.952600E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.44160272397676E-11 |
Normal-vs-N1 |
1.081670E-02 |
N0-vs-N1 |
6.196800E-01 |
|
|